Search
for

    Glossary Bicalutamide

    medication that blocks male hormones to treat prostate cancer

    Bicalutamide, also known by the brand name Casodex, is a medication primarily used to treat prostate cancer. It works as an anti-androgen, meaning it blocks the action of male hormones like testosterone, which can promote the growth of cancer cells.

    Sort by

    Research 30 of 316

    1. Combined Oral Contraception and Bicalutamide in Polycystic Ovary Syndrome and Severe Hirsutism: A Double-Blind Randomized Controlled Trial The Journal of Clinical Endocrinology & Metabolism · 2017 · 25 citations
    2. Optimization, characterization, and follicular targeting assessment of tretinoin and bicalutamide loaded niosomes Scientific Reports · 2023 · 16 citations
    3. Safety of oral bicalutamide in female pattern hair loss: A retrospective review of 316 patients Journal of The American Academy of Dermatology · 2020 · 16 citations
    4. Bicalutamide: A potential new oral antiandrogenic drug for female pattern hair loss Journal of The American Academy of Dermatology · 2020 · 8 citations
    5. Oral bicalutamide for female pattern hair loss: A pilot study Dermatologic Therapy · 2019 · 8 citations
    6. Bicalutamide improves minoxidil-induced hypertrichosis in female pattern hair loss: A retrospective review of 35 patients Journal of The American Academy of Dermatology · 2021 · 4 citations
    7. Bicalutamide and the new perspectives for female pattern hair loss treatment: What dermatologists should know Journal of Cosmetic Dermatology · 2022 · 3 citations
    8. Bicalutamide in Dermatology: A Narrative Review Indian Dermatology Online Journal · 2024 · 1 citations
    9. Comment on “Bicalutamide Improves Minoxidil-Induced Hypertrichosis in Female Pattern Hair Loss: A Retrospective Review of 35 Patients” Journal of The American Academy of Dermatology · 2022 · 1 citations
    10. Phase I-II trial of weekly bicalutamide in men with high PSA and negative biopsy Journal of Clinical Oncology · 2007 · 1 citations
    11. Bicalutamide: A potential new oral anti-androgenic drug for female pattern hair loss - A case series Cosmoderma · 2026
    12. Spironolactone versus Bicalutamide for Female Pattern Hair Loss: A 24-Month Unicenter Retrospective Comparative Study of Effectiveness and Safety Dermatology and Therapy · 2026
    13. Unexpected Hair Regrowth Following Oral Bicalutamide Exposure in a Male Patient With Androgenetic Alopecia and a Suboptimal Response to Conventional Therapies: A Case Report Cureus · 2026
    14. Spironolactone versus Bicalutamide in female pattern hair loss: A randomised clinical trial Clinical and Experimental Dermatology · 2026
    15. Do finasteride and bicalutamide affect blood glucose levels in diabetics? Zenodo (CERN European Organization for Nuclear Research) · 2026
    16. Do finasteride and bicalutamide affect blood glucose levels in diabetics? Zenodo (CERN European Organization for Nuclear Research) · 2026
    17. Efficacy and tolerability of oral bicalutamide in forty postmenopausal women with female pattern hair loss: a retrospective study Actas Dermo-Sifiliográficas · 2025
    18. [[Translated article]]RF- Mesotherapy with Bicalutamide: A Novel Alternative for Androgenetic Alopecia Actas Dermo-Sifiliográficas · 2025
    19. Response to “Improvement of female pattern hair loss with bicalutamide: a time-dependent process” JAAD International · 2025
    20. Improvement of female pattern hair loss with bicalutamide: a time-dependent process JAAD International · 2025
    21. Bioavailability File: Bicalutamide Fabad Journal of Pharmaceutical Sciences · 2025
    22. Highlights from JAAD Reviews: August 2025—Bicalutamide for female hair loss Journal of the American Academy of Dermatology · 2025
    23. Enhanced ex vivo skin retention of bicalutamide using a nano-in-micro composite: Drug-loaded lipid vesicles in a dissolving microarray patch European Journal of Pharmaceutics and Biopharmaceutics · 2025
    24. Efficacy and safety of bicalutamide in female hair loss: a review of the literature JAAD reviews. · 2025
    25. Combination of oral minoxidil and bicalutamide for the treatment of female pattern hair loss in adolescents Journal of the American Academy of Dermatology · 2025
    26. Bicalutamide 25 mg associated with minoxidil 1 mg versus minoxidil 1 mg for female-pattern hair loss: A randomized double-blind clinical trial JAAD International · 2025
    27. Bicalutamide 2025
    28. Bicalutamide: A review Journal of Cutaneous and Aesthetic Surgery · 2024
    29. Mesotherapy with bicalutamide for female pattern hair loss Indian Journal of Dermatology Venereology and Leprology · 2024
    30. Efficacy and safety of spironolactone versus bicalutamide in female pattern hair loss: A retrospective comparative study Australasian journal of dermatology · 2024